临床药师参与泛耐药铜绿假单胞菌肺部感染的治疗实践  

Pharmaceutical Care for Patient with Drug-resistant Pseudomonas Aeruginosa Pulmonary Infection by Clinical Pharmacists

作　　者：曾世全 杨浩江 丁雨韫 邓志亮 李贵龙 ZENG Shiquan;YANG Haojiang;DING Yuyun;DENG Zhiliang;LI Guilong(Dept. of Pharmacy, Yunnan Mengla County People＇s Hospital, Yunnan Mengla 666300, Chin)

机构地区：[1]云南省勐腊县人民医院药剂科,云南勐腊666300

出　　处：《中国医院用药评价与分析》2018年第4期574-576,共3页Evaluation and Analysis of Drug-use in Hospitals of China

摘　　要：目的:探讨临床药师对泛耐药铜绿假单胞菌肺部感染患者实施药学监护的切入点和方法,为临床药师参与抗泛耐药铜绿假单胞菌感染治疗提供参考。方法:回顾性分析临床药师参与的1例泛耐药铜绿假单胞菌肺部感染患者的诊治过程。结果:临床药师全程参与治疗,协助医师制订了磷霉素+阿米卡星+美罗培南的联合抗菌方案,并调整用药时间顺序,获得了满意的疗效。结论:抗泛耐药铜绿假单胞菌感染可考虑采用三联用药方案。临床药师具有专业优势,可在疑难感染的治疗中发挥积极作用。OBJECTIVE： To probe into the pointcuts and methods of pharmaceutical care for patient with drug-resistant pseudomonas aeruginosa pulmonary infection by clinical pharmnaeists, so as to provide reference for participation of clinical pharmacists in the treatment of resistant pseudomonas aeruginosa puhnonary infection. METHODS： Retrospective analysis was conducted on the treatment process of one patient with drug-resistant pseudomonas aeruginosa pulmonary infection participated by clinical pharmacists. RESULTS： The clinical pharmacists participated into the whole treatment process, assisted the clinicians to formulate the combined antimicrobial regimen （fosfomycin ＋ amikacin ＋ meropenem） and adjusted the administration sequence. And then satisfactory efficacy was obtained. CONCLUSIONS： Patient with drag-resistant pseudomonas aeruginosa pulmonary infection can be treated with triple drug regimen. The clinical pharmacists can play active role in the treatment of difficult infection bv their professional advantages.

关 键 词：泛耐药铜绿假单胞菌 肺部感染 临床药师 药学监护 

分 类 号：R978.1[医药卫生—药品]